Blood Flow Measurement Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The blood flow measurement devices market is projected to register a CAGR of 9.2% during the forecast period (2022 - 2027).

The healthcare system has witnessed enormous challenges due to the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to ​reduce the risk of viral transmission, as most chronic therapies were regarded as non-urgent. An article titled “An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: Development and preliminary application” published in the journal PLOS One in March 2021 discussed the development and evaluation of an emergency system for monitoring patients with COVID-19, which may be useful in hospitals. Such developments in the time of the COVID-19 pandemic are expected to propel the growth of the blood flow measurement devices market in the forecast period.

Major chronic diseases, including cardiovascular diseases, are on the rise worldwide, adding to the growth of the blood flow measurement devices market.​ With increasing risks, effective diagnostics also lead to the treatment and monitoring of patients. The rise in cardiovascular disease cases plays an important role in healthcare. In addition, the growing number of factors attributing to the rise in cardiac diseases is increasing the market share for the blood flow measurement devices segment. For instance, according to the key facts on cardiovascular diseases published in June 2021 by the World Health Organization, cardiovascular diseases are the leading cause of death worldwide. The article indicated that in 2019 around 17.9 million people died from cardiovascular diseases, comprising around 32% of all global deaths. The large number of people affected by cardiovascular diseases all over the world is expected to propel the growth of the studied market.

Several research and development studies focusing on innovative blood flow measurement devices are also adding to the growth of the blood flow devices measurement market. For instance, in September 2020, the Government of India Ministry of Science & Technology’s article discussed a new cost-effective blood flow meter device by a team of researchers at the Sree ChitraTirunal Institute for Medical Sciences and Technology. The researchers indicated that the palm-sized device measures blood flow rate using a novel magnetic method and a signal conditioning technique, is compliant with national and international standards and guidelines, and is manufactured using components sourced from established supply chains within the country. Such novel research in the design and manufacturing of blood flow measurement devices is expected to boost the growth of the studied market in the forecast period.

However, the high cost of the blood flow measurement and limited reimbursement scenario are expected to hamper the market growth over the forecast period.

Key Market Trends

The Ultrasound Dopplers Segment is Expected to Hold a Major Market Share in the Blood Flow Measurement Devices Market.

The ultrasound Dopplers hold the major segment in the blood flow measurement devices market. An article titled “Essential notes on the physics of Doppler ultrasound” presented in the journal of BJA Education in April 2020 indicated that the use of low energy, non-ionizing waveform ultrasound in medicine for imaging, therapy, and measurement of blood velocity means that ultrasound exposures are thought to be less hazardous than other imaging modalities, though mild local tissue heating occurs with the absorption of ultrasound energy. The huge advantages of ultrasound Dopplers over other blood flow measurement devices are expected to propel the growth of the segment in the forecast period.

Another article published in the journal of Ultrasonography in December 2020 titled “Usefulness of Doppler sonography in aesthetic medicine” discussed the advantages of ultrasound Dopplers in blood flow measurement for dermal and aesthetic medicines. The article indicated that though imaging skin vessels is rare, the method is very useful in the aesthetics division. The rise in the use of ultrasound Dopplers in various medical sectors is expected to add to the growth of the blood flow measurement devices market in the forecast period.

Also, an article titled “Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis” presented in the British Journal of Radiology in May 2020 evaluated the sensitivity, specificity, and diagnostic odds ratio (DOR) of Doppler ultrasound, CT, and MRI in the diagnosis of Budd Chiari syndrome (BCS). The article suggested that Doppler is an excellent first-line imaging test for patients suspected to have BCS. The advantages of Doppler ultrasound are easy availability and lower cost. Doppler ultrasound also provides functional information regarding stenosis. Such advantages are driving the growth of the market in the study period.

Also, the launch of novel blood flow measurement devices in the market adds to the segment’s growth over the forecast period. For instance, in August 2021, Trivitron launched SonoRad V60 Ultrasound, devoted to delivering excellent imaging systems and exceptional image quality. The device uses innovative color flow technology to improve blood flow visualization.

Such product launches are expected to boost the growth of the studied market during the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period (2022 - 2027).

The rise in the adoption of highly advanced techniques and systems in manufacturing blood flow measurement devices and the technological advancements made in blood flow studies is expected to boost the market's growth in the North American region. The high awareness among the population on the availability of innovative blood flow measurement devices in the market contributes to the high market growth in the region.

The rising number of chronic disease cases in the North American region is adding to the growth of the blood flow measurement devices market.​ Cancer is one of the top ten leading causes of death in the United States. According to the GLOBOCAN 2020 report, the total number of people in the United States affected by cancer in 2020 was around 2,281,658. The number is estimated to rise to 3,123,452 cases by 2040. Per the Heart Disease and Stroke Statistics - 2022 Update published by the American Heart Association, cardiovascular disease accounted for 874,613 deaths in the United States in 2019. Coronary heart disease was the leading cause of death, followed by other cardiovascular diseases, stroke, high blood pressure, heart failure, and artery diseases. The large population affected by cardiac diseases increases the necessity of regular health check-ups to monitor their health conditions. The increasing necessity of blood flow measurement devices for the ease of diagnosis and treatment of such diseases is expected to propel the growth of the blood flow measurement devices market.​

In January 2021, Nuralogix launched the Anura app, allowing contactless blood pressure measurement without needing cuffs or other wearables. Anura measures physical, physiological, and psychological indexes, including heart rate, stress levels, BMI, and cardiovascular disease risks, with an accuracy of medical grade. Launching such innovative devices is expected to boost the market's growth.

Thus the increasing necessity for blood flow measurement devices coupled with increasing investment in the health care department is known to propel the growth of the market in this region.

Competitive Landscape

The blood flow measurement devices market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies currently dominating the market are Cook Group Incorporated, Medistim ASA, Compumedics, Deltex Medical Group, Perimed AB, ADInstruments, Atys Medical, Moor Instruments Ltd., SONOTEC GmbH, Transonic, and others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.